Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000774196 | SCV000907897 | likely benign | Cardiomyopathy | 2018-10-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001456120 | SCV001659896 | likely benign | Charcot-Marie-Tooth disease type 2 | 2023-04-16 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV003231611 | SCV003928182 | uncertain significance | Primary dilated cardiomyopathy | criteria provided, single submitter | research | Potent mutations in LMNA gene can lead to structural alteration in skeletal and cardiac muscle by altering the structure of Lamin A and Lamin C. It is associated with dilated cardiomyopathy and skeletal muscle dystrophies. However no sufficient evidence is found to ascertain the role of this particular variant rs751707982, yet. | |
Gene |
RCV001796209 | SCV004023891 | uncertain significance | not provided | 2023-02-06 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 30402260) |
Clinical Genetics, |
RCV001796210 | SCV002034524 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001796209 | SCV002035417 | likely benign | not provided | no assertion criteria provided | clinical testing |